Narcolepsy News: Latest Narcolepsy Headlines & News Stories at HealthHaven.com

NEWS results 1 - 10 for Narcolepsy

Paladin Labs and GlaxoSmithKline Inc. Sign Agreement on Dexedrine ...
FOXBusiness - Nov 28, 2008
Dexedrine(R) is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) and in the adjunctive treatment of narcolepsy. ...

TSE:PLB - OTC:CMTX

Paladin Labs and GlaxoSmithKline sign agreement on Dexedrine
Therapeutics Daily (press release) (registration), PA - Nov 29, 2008
Financial terms of the transaction for the drug used for the treatment of attention deficit hyperactivity disorder and narcolepsy were not disclosed. ...

TSE:PLB

How a Drug Maker Tries to Outwit Generics
Wall Street Journal - Nov 17, 2008
Twice this year, Cephalon Inc. has sharply raised the price of its narcolepsy drug Provigil. The drug is now 28% more expensive than it was in March and 74% ...
Eyeing Generics, Cephalon Hikes Price on Provigil Wall Street Journal Blogs
all 3 news articles »

CEPH

Novel features narcoleptic heroine
2TheAdvocate, LA - Nov 15, 2008
By GREG LANGLEY It�s not often you encounter a character with narcolepsy in literature. Narcolepsy is a neural disorder that causes its sufferers to ...

Daily Planner: December 1
Enterprise-Record, CA - Nov 30, 2008
NARCOLEPSY SUPPORT GROUP: 7 pm meetings at Congregational Church of Chico, 1190 E. First Ave. 893-4610 (24/7). Weekly. GAMBLERS ANONYMOUS: 7 pm Holt House, ...

Technology Helps Arkansas Fight Meth Manufacturers
Government Technology, CA - 11 hours ago
Developed from ephedrine in Germany in 1887, meth was used to treat many ailments, such as narcolepsy, asthma and obesity. ...

Physicians open eyes to medical issues of sleep
Fort Worth Business Press, TX - 11 hours ago
He sometimes refers patients for sleep disorders like narcolepsy or cataplexy, which is uncontrollable muscle weakness brought on by strong emotions. ...

CEP News

S&P 500 to drop General Growth, add Cephalon
CNNMoney.com - Nov 11, 2008
based Cephalon, which makes Provigil for patients with narcolepsy, meanwhile saw its shares rise 43 cents in a down market Tuesday to $72.43. ...
Cephalon to join S&P 500 Philadelphia Inquirer
all 105 news articles »

CEPH - GGP

Jazz Pharmaceuticals and UCB Announce Positive Phase III Results ...
FOXBusiness - Nov 20, 2008
UCB markets Xyrem(R) (sodium oxybate oral solution) in Europe for the treatment of narcolepsy under a license from Jazz Pharmaceuticals. ...
UPDATE 1-Jazz says fibromyalgia drug meets main goal of study Reuters
Jazz Pharmaceuticals and UCB Announce Positive Phase III Results ... International Business Times
Jazz Pharmaceuticals and UCB Announce Positive Phase III Results ... International Business Times
all 33 news articles »

JAZZ - EBR:UCB

Memphis Daily News

Sleep Treatment Company Targets 24-7 Operations for Growth
Memphis Daily News, USA - Nov 21, 2008
Other sleep disorders that Opus diagnoses and treats are insomnia, narcolepsy, snoring, restless leg syndrome and circadian rhythm disorders. ...

Listen to or join the show...

How to call the show...
1) Make sure the show is live (see graphic above).
2) Dial 724-444-7444.
3) Enter Call ID# 27566 when prompted.
4) Follow the phone prompts to join the call.

Would you like to be a special guest on the show?
Send us an email which includes your contact information and the topic(s) that you would like to discuss.

Listen to past shows
featuring special guests...

Robin Scovill (director)

Richard Diaz (author)

Dr. Kaayla T. Daniel, CCN

Chana de Wolf, (cryonics researcher)

Dr. Mary Ruwart (author & scientist)

Richard Diaz (author)

Dr. Jason Helliwell, OB/GYN